Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.
COVID-19
Intervention
Motivational interviewing
Vaccine hesitancy
Journal
Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
30
07
2021
revised:
29
09
2021
accepted:
10
10
2021
pubmed:
22
11
2021
medline:
15
12
2021
entrez:
21
11
2021
Statut:
ppublish
Résumé
Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75-90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.
Identifiants
pubmed: 34801843
pii: S0033-3506(21)00412-1
doi: 10.1016/j.puhe.2021.10.006
pmc: PMC8520885
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-107Subventions
Organisme : Medical Research Council
ID : MR/P008348/1
Pays : United Kingdom
Informations de copyright
Copyright © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Références
Cochrane Database Syst Rev. 2020 Jan 17;1:CD011895
pubmed: 31978259
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
Expert Rev Vaccines. 2019 Nov;18(11):1167-1185
pubmed: 31791159
Lancet. 2020 Nov 21;396(10263):1614-1616
pubmed: 33159850
BMJ Open. 2020 Sep 15;10(9):e040620
pubmed: 32933965
Vaccine. 2020 Jan 16;38(3):433-443
pubmed: 31806532
Vaccine. 2015 Aug 14;33(34):4191-203
pubmed: 25896385
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Pan Afr Med J. 2021 Mar 02;38:230
pubmed: 34046135
J Med Internet Res. 2020 Jul 17;22(7):e14822
pubmed: 32520718
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009748
pubmed: 22972147
Psychol Med. 2022 Oct;52(14):3127-3141
pubmed: 33305716
Vaccine. 2018 May 11;36(20):2751-2759
pubmed: 29661584
Ann Intern Med. 2021 Jun;174(6):882-885
pubmed: 33556267
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33022917
Early Hum Dev. 2020 Nov 12;:105259
pubmed: 33213968
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Vaccines (Basel). 2021 Jan 20;9(2):
pubmed: 33498395
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Implement Sci. 2019 Feb 1;14(1):11
pubmed: 30709368
Br J Health Psychol. 2020 Nov;25(4):1039-1054
pubmed: 32889759
Can Commun Dis Rep. 2020 Apr 02;46(4):93-97
pubmed: 32281992
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
Am J Prev Med. 2019 Oct;57(4):e125-e133
pubmed: 31471001